How long does it take to see results on Wegovy?

What actually happens in the first few weeks?

The question of how long Wegovy takes to work is one our prescribers hear regularly, and it is usually asked by someone who has already waited longer than they wanted to, whether that was on an NHS list or watching the scales barely move in week three. That frustration is completely understandable.

Wegovy begins at 0.25mg once a week. This starter dose exists to let your body adjust, not to produce weight loss straight away. Many people notice a quieter appetite and less impulse to snack within the first week or two, well before the scales reflect anything significant. That appetite shift (sometimes called reduced food noise) is real and meaningful, but it precedes rather than accompanies the early weight numbers.

By weeks four to eight, when the dose has increased to 0.5mg or 1mg, most people begin to see a modest reduction on the scales. This is typically the phase where the medicine starts doing what it is licensed to do. You can read more about how Wegovy works as the dose builds in our detailed breakdown. NHS guidance on semaglutide confirms that the full effect on weight is not expected until you reach and sustain the maintenance dose.

When do most people see the biggest results on Wegovy?

The steepest phase of weight loss usually falls between months three and twelve, and this is directly tied to where you are in the dose schedule. Wegovy is titrated roughly every four weeks: 0.25mg, 0.5mg, 1mg, 1.7mg, then 2.4mg. Reaching 2.4mg takes around four months, and if you are wondering how long it takes to see results from Wegovy at each stage, our dedicated guide walks through what to expect as the dose increases. From that point, with the full maintenance dose in place, weight loss tends to accelerate.

The STEP 1 trial, published in the New England Journal of Medicine, followed 1,961 adults with obesity over 68 weeks. Those on semaglutide 2.4mg lost an average of approximately 15% of their starting body weight, compared with around 2.4% on placebo. Weight loss continued through the trial rather than plateauing early, which matters: this is a medicine that rewards patience and consistency.

If you are thinking about the overall timeline for losing weight on Wegovy, a reasonable expectation is steady progress from months two through twelve, with some people continuing to lose beyond that on the maintenance dose. Progress under 5% after six months at the highest tolerated dose is a point where your prescriber may review whether continuing makes sense, per NICE's appraisal of semaglutide for weight management (TA875).

What slows or speeds up how quickly you see results?

No two people have identical timelines, and several things shape how quickly results appear.

Starting weight plays a role: people with a higher BMI at baseline sometimes see a larger absolute drop in the early months, even if the percentage lost is similar. Diet matters considerably. Wegovy reduces appetite, but it works alongside a reduced-calorie diet and increased physical activity, the medicine does not replace those changes. People who pair it with consistent protein intake and regular movement tend to see steadier progress; muscle mass supports continued fat loss and protects against the drop in resting metabolism that can accompany rapid weight change.

Tolerance of side effects influences dose progression too. If nausea or digestive symptoms make it necessary to stay at a lower dose longer, the climb to 2.4mg takes more time, which delays the peak effect. This is not a failure, slower titration is often clinically appropriate and the right call. Our Wegovy overview page covers the titration schedule and what to expect at each stage.

For context on how this compares with other treatment options, our weight-loss treatment overview sets out the evidence across the medicines we prescribe. A prescriber can look at your individual picture and help you understand what a realistic timeline might look like for you.

Does Wegovy keep working long term?

Evidence from the STEP 1 trial shows that weight loss continued rather than stalled through 68 weeks of treatment. That said, Wegovy is not a course you complete and then stop, NICE guidance notes that it is used for a maximum of two years in NHS settings, with review at six months. Privately, your prescriber reviews your response before every repeat supply, including whether the medicine is still appropriate.

Stopping Wegovy typically leads to some weight regain over time, which reflects the biology of obesity rather than a personal failing. Many patients also ask how long it takes to see results on Wegovy before they commit to a full course, and our guide on that topic gives a realistic, evidence-based picture of what the journey looks like. Before you even reach that stage, it is also worth understanding how long it takes to get Wegovy, from consultation through to your first pen arriving, so you can plan accordingly. This is why clinical monitoring throughout treatment matters. If you are considering starting or are wondering about next steps, our free consultation is reviewed the same day by a GPhC-registered prescriber, a real clinician, not a form-processing system. They assess your full picture before any prescription is issued.